Sale

Motion Sickness Drugs Market

Global Motion Sickness Drugs Market Size, Share, Demand: By Product: Anticholinergics, Antihistamines; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032

Global Motion Sickness Drugs Market Outlook

The global motion sickness drugs market is projected to grow at a CAGR of 4.20% over the forecast period of 2024-2032.

 

Global Motion Sickness Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global motion sickness drugs market is being driven by the growing use of generic drugs as both over the counter (OTC) and prescription drugs. OTC drugs do not require a professional medical prescription, which has made it more accessible and affordable for consumers. OTC drugs give patients the option for self-medication to relieve mild disease-related symptoms. There are a number of antihistamines used as OTC drugs. This will increase the acceptance of antihistamines to stop motion sickness symptoms, which will further improve the demand for motion sickness drugs. Thus, the availability of over-the-counter (OTC) drugs, along with the advent of nauseogenic information technology, are the factors driving the industry further.

 

Market Segmentation

The global motion sickness drugs market can be broadly categorised based on segments like products and regions.

 

Global Motion Sickness Drugs Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Products:
    • Anticholinergics
    • Antihistamines

The EMR report looks into the regional motion sickness drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Motion Sickness Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

A better understanding of neurological mechanisms associated with motion sickness has been provided by techniques such as traditional neurophysiology, pathway mapping, and magnetic resonance imaging (MRI). Nauseogenic IT has emerged as one of the most popular methods of understanding the neurophysiology and brain parts responsible for this disease. Using nauseogenic vehicles allows to examine postural stability of a person and identifies neural or sensory-motor mechanisms that help to achieve positive body stability. Nauseogenic information technology’s critical knowledge will help develop and improve motion sickness drugs, which will aid the industry growth. Hence, the advancement in nauseogenic information technology coupled with the easy availability and accessibility of OTC drugs are the key factors, which are expected to have a positive impact on the industry growth over the forecast period. However, side effects associated with motion sickness drugs can hamper industry growth over the forecast period.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global motion sickness drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Baxter International Inc. (NYSE: BAX)
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc. 
  • Pfizer Inc. 
  • Prestige Consumer Healthcare Inc. 
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Region
Breakup by Product 
  • Anticholinergics
  • Antihistamines
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Baxter International Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services Inc.
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Motion Sickness Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Motion Sickness Drugs Historical Market (2018-2023) 
    8.3    Global Motion Sickness Drugs Market Forecast (2024-2032)
    8.4    Global Motion Sickness Drugs Market by Product 
        8.4.1    Anticholinergics
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Antihistamines
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032) 
    8.5    Global Motion Sickness Drugs Market by Region
        8.5.1    North America
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Europe
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Asia Pacific
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Latin America
            8.5.4.1    Historical Trend (2018-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Middle East and Africa
            8.5.5.1    Historical Trend (2018-2023)
            8.5.5.2    Forecast Trend (2024-2032)
9    North America Motion Sickness Drugs Market Analysis
    9.1    United States of America
        9.1.1    Historical Trend (2018-2023)
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023)
        9.2.2    Forecast Trend (2024-2032)
10    Europe Motion Sickness Drugs Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Motion Sickness Drugs Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023)
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Motion Sickness Drugs Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023)
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Motion Sickness Drugs Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023)
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Baxter International Inc.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    GlaxoSmithKline PLC
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Johnson & Johnson Services Inc.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Pfizer Inc.
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Prestige Consumer Healthcare Inc.
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Motion Sickness Drugs Market: Key Industry Highlights, 2018 and 2032
2.    Global Motion Sickness Drugs Historical Market: Breakup by Product (USD Million), 2018-2023
3.    Global Motion Sickness Drugs Market Forecast: Breakup by Product (USD Million), 2024-2032
4.    Global Motion Sickness Drugs Historical Market: Breakup by Region (USD Million), 2018-2023
5.    Global Motion Sickness Drugs Market Forecast: Breakup by Region (USD Million), 2024-2032
6.    North America Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
7.    North America Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
8.    Europe Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
9.    Europe Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
10.    Asia Pacific Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
11.    Asia Pacific Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Latin America Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Latin America Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Middle East and Africa Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Middle East and Africa Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Global Motion Sickness Drugs Market Structure

Key Questions Answered in the Report

The global motion sickness drugs market is projected to grow at a CAGR of 4.2% between 2021 and 2026.

The major drivers of the industry, such as the growing sales of generic drugs, particularly OTC (over the counter) drugs, increasing population, increasing health awareness, and the growing research and development activities, are expected to aid the market growth.

Advancements in nauseogenic information technology is the key market trend guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Anticholinergics and antihistamines are the leading products of motion sickness drugs in the market.

The major players in the industry are Baxter International Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Pfizer Inc., and Prestige Consumer Healthcare Inc., among others.

Analyst Review

The global motion sickness drugs market is being driven by the growing demand for OTC (over the counter) drugs and increased investments by the key players in R&D activities. Aided by the growing popularity of nauseogenic information technology, the market is expected to witness a healthy growth in the forecast period of 2024-2032, growing at a CAGR of 4.20%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the industry can be segmented into anticholinergics and antihistamines. The major regional markets for motion sickness drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Baxter International Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Pfizer Inc., Prestige Consumer Healthcare Inc., and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER